Literature DB >> 20837479

The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

Nicole C Smits1, Sindhulakshmi Kurup, Angelique L Rops, Gerdy B ten Dam, Leon F Massuger, Theo Hafmans, Jeremy E Turnbull, Dorothe Spillmann, Jin-ping Li, Stephen J Kennel, Jonathan S Wall, Nicholas W Shworak, P N Richard Dekhuijzen, Johan van der Vlag, Toin H van Kuppevelt.   

Abstract

Heparan sulfate (HS) is a structurally complex polysaccharide that interacts with a broad spectrum of extracellular effector ligands and thereby is thought to regulate a diverse array of biologic processes. The specificity of HS-ligand interactions is determined by the arrangement of sulfate groups on HS, which creates distinct binding motifs. Biologically important HS motifs are expected to exhibit regulated expression, yet there is a profound lack of tools to identify such motifs; consequently, little is known of their structures and functions. We have identified a novel phage display-derived antibody (NS4F5) that recognizes a highly regulated HS motif (HS(NS4F5)), which we have rigorously identified as (GlcNS6S-IdoA2S)(3). HS(NS4F5) exhibits a restricted expression in healthy adult tissues. Blocking HS(NS4F5) on cells in culture resulted in reduced proliferation and enhanced sensitivity to apoptosis. HS(NS4F5) is up-regulated in tumor endothelial cells, consistent with a role in endothelial cell activation. Indeed, TNF-α stimulated endothelial expression of HS(NS4F5), which contributed to leukocyte adhesion. In a mouse model of severe systemic amyloid protein A amyloidosis, HS(NS4F5) was expressed within amyloid deposits, which were successfully detected by microSPECT imaging using NS4F5 as a molecularly targeted probe. Combined, our results demonstrate that NS4F5 is a powerful tool for elucidating the biological function of HS(NS4F5) and can be exploited as a probe to detect novel polysaccharide biomarkers of disease processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837479      PMCID: PMC3003412          DOI: 10.1074/jbc.M110.153791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 4.  Heparan sulfate fine structure and specificity of proteoglycan functions.

Authors:  Hiroshi Nakato; Koji Kimata
Journal:  Biochim Biophys Acta       Date:  2002-12-19

5.  Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.

Authors:  D Leali; M Belleri; C Urbinati; D Coltrini; P Oreste; G Zoppetti; D Ribatti; M Rusnati; M Presta
Journal:  J Biol Chem       Date:  2001-07-25       Impact factor: 5.157

6.  Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

Authors:  J Kreuger; M Salmivirta; L Sturiale; G Giménez-Gallego; U Lindahl
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

7.  Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.

Authors:  Michel A B A Dennissen; Guido J Jenniskens; Martijn Pieffers; Elly M M Versteeg; Maurice Petitou; Jacques H Veerkamp; Toin H van Kuppevelt
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

8.  Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.

Authors:  G J Jenniskens; A Oosterhof; R Brandwijk; J H Veerkamp; T H van Kuppevelt
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

9.  Amyloid-specific heparan sulfate from human liver and spleen.

Authors:  B Lindahl; U Lindahl
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

10.  Differential expression of heparan sulfate domains in rat spleen.

Authors:  Gerdy B ten Dam; Theo Hafmans; Jacques H Veerkamp; Toin H van Kuppevelt
Journal:  J Histochem Cytochem       Date:  2003-06       Impact factor: 2.479

View more
  28 in total

1.  SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Arie Oosterhof; Toin H van Kuppevelt; Nicole C Smits; Stephen J Kennel
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

2.  Development and evaluation of agents for targeting visceral amyloid.

Authors:  Jonathan S Wall; Alan Solomon; Stephen J Kennel
Journal:  Tijdschr Nucl Geneeskd       Date:  2011-12

3.  In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Sallie Macy; Emily B Martin; Angela Williams; Keiichi Higuchi; Stephen J Kennel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

4.  Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils.

Authors:  Michael W Risør; Dennis W Juhl; Morten Bjerring; Joachim Mathiesen; Jan J Enghild; Niels C Nielsen; Daniel E Otzen
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

5.  Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells.

Authors:  Trine M Reine; Marion Kusche-Gullberg; Almir Feta; Trond Jenssen; Svein O Kolset
Journal:  Glycoconj J       Date:  2011-12-22       Impact factor: 2.916

6.  Improved liquid chromatography-MS/MS of heparan sulfate oligosaccharides via chip-based pulsed makeup flow.

Authors:  Yu Huang; Xiaofeng Shi; Xiang Yu; Nancy Leymarie; Gregory O Staples; Hongfeng Yin; Kevin Killeen; Joseph Zaia
Journal:  Anal Chem       Date:  2011-10-07       Impact factor: 6.986

Review 7.  Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.

Authors:  Nousheen Zaidi; Leslie Lupien; Nancy B Kuemmerle; William B Kinlaw; Johannes V Swinnen; Karine Smans
Journal:  Prog Lipid Res       Date:  2013-08-31       Impact factor: 16.195

8.  Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation.

Authors:  Minh Bao Huynh; Christophe Morin; Gilles Carpentier; Stephanie Garcia-Filipe; Sofia Talhas-Perret; Véronique Barbier-Chassefière; Toin H van Kuppevelt; Isabelle Martelly; Patricia Albanese; Dulce Papy-Garcia
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

9.  Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells.

Authors:  Leslie E Lupien; Katarzyna Bloch; Jonas Dehairs; Nicole A Traphagen; William W Feng; Wilson L Davis; Thea Dennis; Johannes V Swinnen; Wendy A Wells; Nicole C Smits; Nancy B Kuemmerle; Todd W Miller; William B Kinlaw
Journal:  J Lipid Res       Date:  2019-12-05       Impact factor: 5.922

10.  A novel method for quantifying peripheral tissue amyloid load by using the radiolabeled amyloidophilic peptide, p5.

Authors:  Jonathan S Wall; Tina Richey; Sally Macy; Eric Heidel; Craig Wooliver; Stephen J Kennel
Journal:  Amyloid       Date:  2013-01-17       Impact factor: 7.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.